Regazzi MB - Search Results

1

High-performance liquid chromatography determination of pravastatin in plasma.

Iacona I, Regazzi MB, Buggia I, Villani P, Fiorito V, Molinaro M, Guarnone E. Iacona I, et al. Among authors: regazzi mb. Ther Drug Monit. 1994 Apr;16(2):191-5. doi: 10.1097/00007691-199404000-00014. Ther Drug Monit. 1994. PMID: 8009569

2

High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.

Villani P, Pregnolato M, Banfo S, Rettani M, Burroni D, Seminari E, Maserati R, Regazzi MB. Villani P, et al. Among authors: regazzi mb. Ther Drug Monit. 1999 Jun;21(3):346-50. doi: 10.1097/00007691-199906000-00018. Ther Drug Monit. 1999. PMID: 10365651 Clinical Trial.

3

Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.

Regazzi MB, Molinaro M, Tinelli C, D'Eril GM, Goggi C, Campana C, Fiorito V, Moratti R, Viganò M. Regazzi MB, et al. Ther Drug Monit. 2000 Dec;22(6):712-5. doi: 10.1097/00007691-200012000-00010. Ther Drug Monit. 2000. PMID: 11128239

4

Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.

Villani P, Feroggio M, Gianelli L, Bartoli A, Montagna M, Maserati R, Regazzi MB. Villani P, et al. Among authors: regazzi mb. Ther Drug Monit. 2001 Aug;23(4):380-8. doi: 10.1097/00007691-200108000-00010. Ther Drug Monit. 2001. PMID: 11477320

5

Assessment of an LC-MS method for plasma quantification of the new immunosuppressant FK778 through comparison with HPLC-UV.

Molinaro M, Carazzone C, Barbano D, Abbiati F, Alessiani M, Regazzi M. Molinaro M, et al. Transplant Proc. 2005 Jul-Aug;37(6):2722-7. doi: 10.1016/j.transproceed.2005.06.069. Transplant Proc. 2005. PMID: 16182794

6

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.

Baroncelli S, Villani P, Galluzzo CM, Cavalli A, Volpe A, Francisci D, Vivarelli A, Sozio F, Tedeschi S, Cirioni O, Sighinolfi L, Cusato M, Pirillo MF, Weimer LE, Fragola V, Parruti G, Regazzi M, Floridia M. Baroncelli S, et al. Ther Drug Monit. 2013 Dec;35(6):785-90. doi: 10.1097/FTD.0b013e31829ad690. Ther Drug Monit. 2013. PMID: 24061444

7

Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers.

De Gregori S, Cipollina L, De Silvestri A, Ventura M, Michelini R, Morosini M, Montagna M, Tinelli C, Regazzi M, Molinaro M, Imberti R. De Gregori S, et al. Ther Drug Monit. 2017 Apr;39(2):118-123. doi: 10.1097/FTD.0000000000000380. Ther Drug Monit. 2017. PMID: 28196046 Clinical Trial.

8

Monoclonal Antibody Monitoring: Clinically Relevant Aspects, A Systematic Critical Review.

Regazzi M, Golay J, Molinaro M. Regazzi M, et al. Ther Drug Monit. 2020 Feb;42(1):45-56. doi: 10.1097/FTD.0000000000000681. Ther Drug Monit. 2020. PMID: 31365482

9

[The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations].

Molinaro M, Villani P, Buggia I, Iacona I, Zoia C, Regazzi MB, Rondanelli R. Molinaro M, et al. Among authors: regazzi mb. Boll Chim Farm. 1992 Nov;131(10):375-9. Boll Chim Farm. 1992. PMID: 1296704 Italian.

10

The effect of aging on the pharmacokinetics of nizatidine.

Villani P, Regazzi MB, Pecorini M, Tizzoni M, Savio D. Villani P, et al. Among authors: regazzi mb. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:205-10. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page